AzTrials
AzTrials

Dyssynergic DefaecationNCT07488442

Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation

A study testing Pelvic floor rehabilitation and Pelvic floor rehabilitation+cognitive behavioral therapy in people with Dyssynergic Defaecation, run by Ankara Etlik City Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effectiveness of cognitive-behavioral therapy when used in conjunction with lifestyle modifications and pelvic floor rehabilitation. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Dyssynergic Defaecation
What is being tested?
Pelvic floor rehabilitation and Pelvic floor rehabilitation+cognitive behavioral therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Mar 2026to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • A history of constipation lasting longer than one year
  • Chronic constipation as defined by the Rome IV criteria
  • Being between the ages of 18 and 55
  • Findings consistent with dyssynergic defecation on anorectal manometry and balloon defecography
  • Exclusion of organic and metabolic causes of chronic constipation

Who cannot join

  • Active bowel disease
  • Presence of an active anal fissure
  • History of major abdominal surgery
  • Presence of a neurological disorder
  • Presence of a serious psychiatric disorder
  • Use of medications that cause constipation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayşe Naz Kalem Ozgen, specialist contact

+90 0312 797 00 00

kalemnaz@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara Etlik City Hospital

    Ankara, Yenimahalle, 06010

    Ayse Naz Kalem Ozgen, Specialist, +90 0312 797 00 00, kalemnaz@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: An Evaluation of the Efficacy of Cognitive Behavioral Therapy Administered in Conjunction With Pelvic Floor Exercises in Patients With Dyssynergic Defecation

The aim of this study is to evaluate the effectiveness of cognitive-behavioral therapy when used in conjunction with lifestyle modifications and pelvic floor rehabilitation.

Being tested
Pelvic floor rehabilitation, Pelvic floor rehabilitation+cognitive behavioral therapy
Keywords
Dyssynergic Defecation, Cognitive Behavioral Therapy, Pelvic Floor Rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pelvic floor rehabilitationOther

    Relaxation and kegel exercises and biofeedback therapy

  • Pelvic floor rehabilitation+cognitive behavioral therapyBehavioural

    Relaxation and kegel exercises, biofeedback therapy and cognitive behavioral therapy

Study groups in NCT07488442
Study groupRoleWhat they receive
Pelvic floor rehabilitationActive comparatorPatients in the first group will receive education on lifestyle changes, and a rehabilitation program consisting of 15 sessions of relaxation and Kegel exercises-held three days a week at the pelvic floor unit-will be planned.
Receives: Other: Pelvic floor rehabilitation
Pelvic floor rehabilitation+cognitive behavioral therapyExperimentalIn addition to these treatments, patients in the second group will receive a total of five sessions of cognitive-behavioral therapy from a certified psychologist specializing in the field, focusing on their current gastrointestinal issues rather than their personal histories.
Receives: Behavioral: Pelvic floor rehabilitation+cognitive behavioral therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wexner Constipation Score

    Measured: first day of treatment and 5th week of treatment

  2. Constipation Severity Scale

    Measured: first day of treatment and 5th week of treatment

Secondary outcomes (2)
  1. Bristol Stool Chart

    Measured: first day of treatment and 5th week of treatment

  2. Beck Depression Scale

    Measured: first day of treatment and 5th week of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2026
  2. Study start30 Mar 2026
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
26 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07488442
Sponsor's protocol ID
AEŞH-EK-2025-314
Status last verified
Mar 2026
First submitted
18 Mar 2026
Last updated
30 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Pelvic floor rehabilitation and Pelvic floor rehabilitation+cognitive behavioral therapy in people with Dyssynergic Defaecation, run by Ankara Etlik City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayşe Naz Kalem Ozgen, specialist (+90 0312 797 00 00, kalemnaz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wexner Constipation Score (time frame: first day of treatment and 5th week of treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in